News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Canada's EndoCeutics Lowers IPO Price to $7-$9



5/10/2007 8:56:41 AM

WASHINGTON, May 9 (Reuters) - Canada's EndoCeutics Inc., a pharmaceutical firm, lowered the price of its planned initial public offering to between $7 and $9 per share from between $11-$13 each.

>>> Discuss This Story


Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES